Preliminary study of frontal lobe 1H MR spectroscopy in childhood- onset schizophrenia

Journal of Magnetic Resonance Imaging

Volumn 8, Issue 4, 1998, Pages 841-846

  Thomas, M Albert ^a   Ke, Yong ^a   Levitt, Jennifer ^a   Caplan, Rochelle ^a   Curran, John ^a   Asarnow, Robert ^a   McCracken, James ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Frontal lobe; Glutamine glutamate; N acetyl aspartate; Proton MR spectroscopy; Schizophrenia; Steam sequence

Indexed keywords

CHOLINE; GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID;

ADOLESCENT; ARTICLE; BRAIN DEVELOPMENT; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; TISSUE DISTRIBUTION;

ADOLESCENT; ASPARTIC ACID; BRAIN CHEMISTRY; CASE-CONTROL STUDIES; CHILD; CREATINE; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PILOT PROJECTS; SCHIZOPHRENIA;

EID: 0031823997     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880080413     Document Type: Article

References (39)

1. Pfefferbaum A, Marsh L. Structural brain imaging in schizophrenia. Clin Neurosci 1995; 3:105-111.
2. Asarnow AR, Asarnow JR. Childhood onset schizophrenia: editor's introduction. Schiz Bull 1994; 20:591-597.
3. Andreasen NC, Flashman L, Flaum M, et al. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA 1994; 272:1763-1769.
4. Kotrala KJ, Weinberger DR. Brain imaging in schizophrenia. Ann Rev Med 1995; 46:113-122.
5. Andreasen NC, Arndt S, Swayze V, et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994; 266:294-298.
6. Taubes G. Averaged brains pinpoint a site for schizophrenia. Science 1994; 266:221.
7. Turetsky B, Cowell PE, Gur RC, et al. Frontal and temporal lobe brain volumes in schizophrenia. Arch Gen Psychiatry 1995; 52: 1061-1070.
8. Woodruff PWR, McManus IC, David AS. Meta-analysis of corpus callosum size in schizophrenia. J Neurol Neurosurg Psychiatry 1995; 58:457-461.
9. Menon RR, Barta PE, Aylward EH, et al. Posterior superior temporal gyrus in schizophrenia: gray matter changes and clinical correlates. Schiz Res 1995; 16:127-135.
10. Wible CG, Shenton ME, Hokama H, et al. Prefrontal cortex and schizophrenia. Arch Gen Psychiatry 1995; 52:279-288.
11. Crow TJ. Brain Changes and negative symptoms in schizophrenia. Psychopathology 1995; 28:18-21.
12. Buckley P, O'Callaghan E, Mulvany F, et al. Basal ganglia T2 relaxation times in schizophrenia: a quantitative magnetic resonance imaging study in relation to tardive dyskinesia. Psychiatry Res Neuroimaging 1995; 61:95-102.
13. Andreasen NC, O'Leary DS, et al. Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci USA 1996; 93:9985-9990.
14. Keshavan MS, Sanders RD, Pettegrew JW, Dombrowsky SM, Panchalingam KS. Frontal lobe metabolism and cerebral morphology in schizophrenia: 31P MRS and MRI studies. Schiz Res 1993; 10:241-246.
15. Nasrallah HA, Skinner TE, Schmalbrock P, Robitaille PM. Proton magnetic resonance spectroscopy of the hippocampal formation in schizophrenia: a pilot study. Brit J Psychiatry 1994; 165:481-485.
16. Buckley PF, Moore C, Long H, Larkin C, et al. 1H magnetic resonance spectroscopy of the left frontal and temporal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biol Psych 1994; 36:792-800.
17. Deicken RF, Calabrese G, Merrin EL, et al. Asymmetry of temporal lobe phosphorus metabolism in schizophrenia: a phosphorus magnetic resonance spectroscopic imaging study. Biol Psychiatry 1995; 38:279-286.
18. Stanley JA, Williamson PC, Drost DJ, et al. an in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch Gen Psychiatry 1995; 52:399-406.
19. Kato T, Shioiri T, Murashita J, et al. Laterized abnormality of high energy phosphate and bilateral reduction of phopshomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia. Psychiatry Res Neuroimaging 1995; 61:151-160.
20. American Psychiatric Association. DSM-III-R: diagnostic and statistical manual of mental disorders, 3rd Ed. Washington, DC: American Psychiatric Association, 1994.
21. Frahm J, Brunn H, Gyngell ML, Merboldt MD, Hanicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989; 9:79-93.
22. Moonen CTW, von Kienlin M, van Zijl PCM, Cohen J, Gillen J, Daly P, Wolf G. Comparison of single shot localization methods (STEAM and PRESS) for in vivo proton NMR spectra. NMR Biomed 1989; 2:201-208.
23. Brunn H, Frahm, J, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy. Mag Reson Med 1989; 9:126-131.
24. Kreis R, Ross BD, Farrow N, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with 1H MR spectroscopy. Radiology 1992; 182:9-27.
25. Jehenson P, Syrota A. Corrections of distortions due to the pulsed magnetic field gradient-induced shift in B0 field by post-processing. Magn Reson Med 1989; 12:253-256.
26. Klose U. In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 1990; 14:26-30.
27. Olney JW, Farber NB. Glutamate receptor dysfunction in schizophrenia. Arch Gen Psychiatry 1995; 52:998-1007.
28. Kim JS, Kornhaebr HH, Schmid-Burg KW, Holzmuller B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neuropsych Lett 1980; 20: 379-382.
29. Perry TL. Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction. Neurosci Lett 1982; 28:81-85.
30. Lodge D, Aram JA, Church J, et al. Excitatory amino acids and phencyclidine-like drugs. In: Hick TP, Lodge D, McLennan H, eds. Excitatory amino acid transmission. New York: Alan R. Liss, Inc., 1987; 83-90.
31. 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA 1993; 90:5662-5666.
32. Ryner LN, Sorenson JA, Thomas MA. 3D localized 2D NMR spectroscopy on an MRI scanner. J Magn Reson 1995; B107: 126-137.
33. 1H MR spectroscopy of human brain tumors in vivo. J Magn Reson Imaging 1996; 6:453-459.
34. van der Knaap MS, Valk J. MR imaging of the various stages of normal myelination during the first year of life. Neuroradiology 1990; 31:459-470.
35. van der Grond J, van Rijen PC, Faber JAJ, Falk J, Willemse K. Age dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 1990; 176:309-313.
36. Toft PB, Leth H, Lou HC, Pryds O, Henriksen O. Metabolite concentrations in the developing brain estimated with proton MR spectroscopy. J Magn Reson Imaging 1994; 4:674-680.
37. Hashimoto T, Tayama M, Miyazaki M, et al. Developmental brain changes investigated with proton magnetic resonance spectroscopy. Dev Med Child Neurol 1995; 37:398-405.
38. Ernst T, Kreis R, Ross BD. Absolute quantitation of water and metabolites in the human brain: I - compartments and water. J Magn Reson 1993; B102-1-8.
39. Danielsen ER, Michaelis T, Ross BD. Three methods of calibration in quantitative proton MR spectroscopy. J Magn Reson 1995; B106:287-291.